National Asthma Education and Prevention Program.Expert Panel Report 3: guidelines for the Diagnosis and Management of Asthma . Full Report-2007. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2007.
2.
Dodge R., Martinez FD, Cline MG, Lebowitz MD, Burrows B.Early childhood respiratory symptoms and the subsequent diagnosis of asthma . J Allergy Clin Immunol. 1996;98:48-54.
3.
Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-138.
4.
American Academy of Allergy, Asthma & Immunology (AAAAI).Pediatric Asthma: Promoting Best Practice. Guide for Managing Asthma in Children. Milwaukee, WI: American Academy of Allergy, Asthma & Immunology, Inc; 2004:1-143.
5.
Chipps BE, Spahn JD, Sorkness A., et al. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting β2-agonists. J Pediatr . 2006;148:517-521.
6.
Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FDA clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-1406.
7.
Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114:1282-1287.
8.
Guilbert TW, Morgan WJ, Krawiec M., et al. The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials. 2004;25:286-310.
9.
Bisgaard H., Szefler SJUnderstanding mild persistent asthma in children: the next frontier. J Allergy Clin Immunol. 2005;115:708-713.
10.
Strunk RCDefining asthma in the preschool-aged child. Pediatrics. 2002;109:357-361.
11.
Global Strategy for Asthma Management and Prevention.Global Initiative for Asthma (GINA)2006. http://www.ginasthma.org. Updated December 10, 2007.
Eigen H., Bieler H., Grant D., et al. Spirometric pulmonary function in healthy preschool children . Am J Respir Crit Care Med. 2001;163:619-623.
14.
Stein RT, Holberg CJ, Morgan WJ, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax. 1997;52:946-952.
15.
Illi S., von Mutius E., Lau S., Niggemann B., Gruber C., Wahn U.Perennial allergen sensitization early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368:763-770.
16.
Svedmyr J., Nyberg E., Thunqvist P., Asbrink-Nilsson E., Hedlin G.Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers. Acta Paediatr . 1999;88:42-47.
17.
Murray CS, Woodcock A., Langley SJ, Morris J., Custovic A.; for the IFWIN study team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy Infants (IFWIN): double-blind, randomized, controlled study. Lancet. 2006;368:754-762.
18.
McKean M., Ducharme F.Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev. 2005;(2):CD001107.
19.
Teper AM, Kofman CD, Szulman GA, et al. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med. 2005;171:587-590.
20.
Guilbert TW , Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med . 2006;354:1985-1997.
21.
Bisgaard H. , Hermansen MN, Loland L., Halkjaer LB, Buchvald F.Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006 ;354: 1998-2005.
22.
Martinez FDInhaled corticosteroids and asthma prevention . Lancet. 2006;368:708-710.
23.
Bisgaard J. , Zielen S., Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171:315-322.
24.
Barnes PJ, Pedersen S., Busse WWEfficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med. 1998;157:S1-S53.
25.
The Childhood Asthma Management Program Research Group.Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343: 1054-1063.
26.
Leone FT, Fish JE, Szefler SJ, West SLSystematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest. 2003;124:2329-2340.
27.
Busse W., Raphael GD, Galant S., et al; for the Fluticasone Propionate Clinical Research Study Group. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. J Allergy Clin Immunol. 2001;107:461-468.
28.
Garcia Garcia ML, Wahn U., Gilles L., Swern A., Tozzi CA, Polos P.Montelukast, compared with Fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics. 2005;116: 360-369.
29.
Ostrom NK, Decotiis BA, Lincourt WR, et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr . 2005;147:213-220.
30.
Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol . 2005;115:233-242.
31.
NAPS document no. 05569, c/o Microfiche Publications, West Hempstead, NY.